197 related articles for article (PubMed ID: 16835746)
1. High-dose chemotherapy and autologous peripheral blood stem cell transplantation in adult patients with high-risk or advanced Ewing and soft tissue sarcoma.
Engelhardt M; Zeiser R; Ihorst G; Finke J; Müller CI
J Cancer Res Clin Oncol; 2007 Jan; 133(1):1-11. PubMed ID: 16835746
[TBL] [Abstract][Full Text] [Related]
2. Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma.
Lashkari A; Chow WA; Valdes F; Leong L; Phan V; Twardowski P; Kapoor N; Molina A; Al-Kadhimi Z; Frankel P; Somlo G
Anticancer Res; 2009 Aug; 29(8):3281-8. PubMed ID: 19661346
[TBL] [Abstract][Full Text] [Related]
3. High-dose chemotherapy for Ewing sarcoma and Rhabdomyosarcoma: A systematic review by the Australia and New Zealand sarcoma association clinical practice guidelines working party.
Ramamurthy A; Connolly EA; Mar J; Lewin J; Bhadri VA; Phillips MB; Winstanley M; Orme LM; Grimison P; Connor J; Lazarakis S; Hong AM; Omer N; Cayrol J
Cancer Treat Rev; 2024 Mar; 124():102694. PubMed ID: 38325070
[TBL] [Abstract][Full Text] [Related]
4. High-dose chemotherapy with autologous peripheral blood stem cell transplantation for bone and soft-tissue sarcomas.
Kasper B; Lehnert T; Bernd L; Mechtersheimer G; Goldschmidt H; Ho AD; Egerer G
Bone Marrow Transplant; 2004 Jul; 34(1):37-41. PubMed ID: 15170176
[TBL] [Abstract][Full Text] [Related]
5. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
[TBL] [Abstract][Full Text] [Related]
6. High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience.
Rodriguez J; Caballero MD; Gutierrez A; Gandarillas M; Sierra J; Lopez-Guillermo A; Sureda A; Zuazu J; Marin J; Arranz R; Carreras E; Leon A; De Sevilla AF; San Miguel JF; Conde E;
Haematologica; 2003 Dec; 88(12):1372-7. PubMed ID: 14687990
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow.
Thiel U; Wawer A; von Luettichau I; Bender HU; Blaeschke F; Grunewald TG; Steinborn M; Röper B; Bonig H; Klingebiel T; Bader P; Koscielniak E; Paulussen M; Dirksen U; Juergens H; Kolb HJ; Burdach SE
Oncotarget; 2016 Oct; 7(43):70959-70968. PubMed ID: 27486822
[TBL] [Abstract][Full Text] [Related]
8. Autologous hematopoietic stem cell transplantation following high dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas.
Peinemann F; Smith LA; Bartel C
Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD008216. PubMed ID: 23925699
[TBL] [Abstract][Full Text] [Related]
9. High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Children with High-Risk or Recurrent Bone and Soft Tissue Sarcomas.
Choi YB; Yi ES; Lee JW; Yoo KH; Sung KW; Koo HH
J Korean Med Sci; 2016 Jul; 31(7):1055-62. PubMed ID: 27366002
[TBL] [Abstract][Full Text] [Related]
10. High-dose chemotherapy with autologous hematopoietic stem-cell transplantation for advanced soft tissue sarcoma in adults.
Blay JY; Bouhour D; Ray-Coquard I; Dumontet C; Philip T; Biron P
J Clin Oncol; 2000 Nov; 18(21):3643-50. PubMed ID: 11054437
[TBL] [Abstract][Full Text] [Related]
11. Response of children with stage IV soft tissue sarcoma to topotecan and carboplatin: a phase II window trial of the cooperative soft tissue sarcoma group.
Bochennek K; Dantonello T; Koscielniak E; Claviez A; Dirksen U; Sauerbrey A; Beilken A; Klingebiel T
Klin Padiatr; 2013 Nov; 225(6):309-14. PubMed ID: 23946091
[TBL] [Abstract][Full Text] [Related]
12. Treatment of sarcomas of the chest wall using intensive combined modality therapy.
Young MM; Kinsella TJ; Miser JS; Triche TJ; Glaubiger DL; Steinberg SM; Glatstein E
Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):49-57. PubMed ID: 2643597
[TBL] [Abstract][Full Text] [Related]
13. Treatment of pelvic sarcomas in adolescents and young adults with intensive combined modality therapy.
Stea B; Kinsella TJ; Triche TJ; Horvath K; Glatstein E; Miser JS
Int J Radiat Oncol Biol Phys; 1987 Dec; 13(12):1797-805. PubMed ID: 3679916
[TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.
Kim MK; Kim S; Lee SS; Sym SJ; Lee DH; Jang S; Park CJ; Chi HS; Huh J; Suh C
Ann Hematol; 2007 Jun; 86(6):435-42. PubMed ID: 17256144
[TBL] [Abstract][Full Text] [Related]
15. Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?
Al-Faris N; Al Harbi T; Goia C; Pappo A; Doyle J; Gassas A
Pediatr Blood Cancer; 2007 Aug; 49(2):190-5. PubMed ID: 17262797
[TBL] [Abstract][Full Text] [Related]
16. Retrospective Analysis of Outcomes of Patients with Relapsed, Refractory and Metastatic Sarcomas who have received Metronomic Chemotherapy.
Devadas SK; Banavali S
Gulf J Oncolog; 2019 May; 1(30):22-28. PubMed ID: 31242978
[TBL] [Abstract][Full Text] [Related]
17. [Megachemotherapy and autologous stem cell transplantation in children with Ewing sarcoma - Polish experience].
Drabko K; Zaucha-Prazmo A; Choma M; Wójcik B; Dyla A; Paździor D; Kałwak K; Chybicka A; Skoczeń S; Goździk J; Styczyński J; Wysocki M; Kowalczyk J
Med Wieku Rozwoj; 2008; 12(4 Pt 2):1069-73. PubMed ID: 19531828
[TBL] [Abstract][Full Text] [Related]
18. High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission.
Papajik T; Raida L; Faber E; Vondrakova J; Prochazka V; Kubova Z; Skoumalova I; Jarosova M; M LK; Paucek B; Myslivecek M; Neoral C; Oral I; Jarkovsky J; Dusek L; Indrak K
Neoplasma; 2008; 55(3):215-21. PubMed ID: 18348654
[TBL] [Abstract][Full Text] [Related]
19. High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma.
Boulad F; Kernan NA; LaQuaglia MP; Heller G; Lindsley KL; Rosenfield NS; Abramson SJ; Gerald WL; Small TN; Gillio AP; Gulati SC; O'Reilly RJ; Ghavimi F
J Clin Oncol; 1998 May; 16(5):1697-706. PubMed ID: 9586881
[TBL] [Abstract][Full Text] [Related]
20. "Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma.
Gasparetto C; Gockerman JP; Diehl LF; de Castro CM; Moore JO; Long GD; Horwitz ME; Keogh G; Chute JP; Sullivan KM; Neuwirth R; Davis PH; Sutton LM; Anderson RD; Chao NJ; Rizzieri D
Biol Blood Marrow Transplant; 2010 Jan; 16(1):70-7. PubMed ID: 19733251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
